Biohacking, once a fringe tech trend, has exploded into a mainstream wellness movement driven by DIY approaches to diet and health monitoring. Americans increasingly rely on self-tracking tools like continuous glucose monitors and blood panels without prescriptions, bypassing traditional medical gatekeepers. The global dietary supplement market, now valued at $209.5 billion and projected to double by 2033, fuels this shift, with products like Athletic Greens seeing 16% sales growth. This surge reflects broader distrust in conventional healthcare systems and rising medical costs, as consumers turn to unregulated supplements and wearable tech for perceived control over their well-being.

The movement’s accessibility has democratized biohacking: no longer limited to wealthy tech insiders, it now appeals to everyday people like Lydia Christofferson, a nursing professor using greens powder and Shilajit for perimenopause, or Maya Rockeymoore Cummings, a seed-cycling advocate frustrated by systemic healthcare failures. Social media and AI tools like ChatGPT amplify these trends, offering personalized health “hacks” such as seed cycling or carb-timing diets. Yet experts warn of risks: supplements lack FDA oversight, and isolated data tracking ignores holistic care. Dr. Anna Wexler, a medical ethics professor, cautions that this DIY approach prioritizes convenience over evidence, leaving gaps in comprehensive health management.

For some, biohacking fills critical voids. Shalini Vijayan, a violinist with elevated cholesterol, uses a glucose monitor to identify trigger foods like rice, while Rachael Band employs seed cycling to address infertility gaps unaddressed by doctors. These stories highlight how marginalized groups, particularly Black women like Cummings, leverage biohacking to challenge medical neglect. Yet the trend’s reliance on anecdotal success stories—like Cummings’ belief that MCT oil boosts metabolism—risks perpetuating misinformation.

As biohacking reshapes wellness culture, its business implications loom large. Companies peddling unproven products thrive, while regulators grapple with closing loopholes. The rise of direct-to-consumer health tech underscores a societal pivot: people are trading doctor’s offices for spreadsheets and smartwatches, betting on self-optimization in an era of medical skepticism.